Mr. Adrian Mendes reports

PERIMETER MEDICAL IMAGING AI ANNOUNCES EXPANDED COMMERCIAL PRESENCE WITHIN NATIONAL HEALTHCARE PROVIDER SYSTEM WITH FOLLOW-ON PLACEMENT OF PERIMETER S-SERIES OCT AT ADDITIONAL HOSPITAL SITE

Perimeter Medical Imaging AI Inc. has made a further commercial expansion within a major national health care system with a follow-on placement of its flagship Perimeter S-Series OCT (optical coherence tomography) system at a new hospital site in north Texas.

Adrian Mendes, Perimeter's chief executive officer, stated: "Our continued expansion within a major national health care system further validates our belief that our surgeon customers recognize the value of Perimeter S-Series in their ORs [operating rooms] and the potential benefits to their patients. Combining a surgeon's clinical expertise with OCT technology has the potential to reduce repeat surgeries due to cancer left behind, and we believe Perimeter's innovative technology can become the standard of care in cancer surgery."

Perimeter's flagship product, the S-Series OCT, is a pioneering medical imaging system that provides cross-sectional, real-time margin visualization of excised tissue specimens in the operating room at 10 times higher image resolution than X-ray and ultrasound and 100 times greater image resolution than MRI (magnetic resonance imaging).

About Perimeter Medical Imaging AI, Inc.

Based in Toronto, Canada, and Dallas, Tex., Perimeter Medical Imaging AI is a medical technology company driven to transform cancer surgery with ultrahigh-resolution, real-time, advanced imaging tools to address areas of high unmet medical need. Available across the United States, its FDA-cleared (U.S. Food and Drug Administration) Perimeter S-Series OCT system provides real-time, cross-sectional visualization of excised tissues at the cellular level. The breakthrough-device-designated investigational Perimeter B-Series OCT with ImgAssist AI represents the company's next-generation artificial intelligence technology that is currently being evaluated in a pivotal clinical trial, with support from a grant of up to $7.4-million (U.S.) awarded by the Cancer Prevention and Research Institute of Texas. The company's ticker symbol PINK is a reference to the pink ribbons used during Breast Cancer Awareness Month.

We seek Safe Harbor.